That’s an odd thing for an analyst to write; Teva’s own publicly stated goal is to maintain the same mix of generic (70%) and branded (30%) sales that it has today.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.